Published in Am J Psychiatry on March 01, 1994
Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci U S A (1998) 3.99
Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures. Schizophr Bull (2006) 2.92
Realistic expectations of prepulse inhibition in translational models for schizophrenia research. Psychopharmacology (Berl) (2008) 2.64
Preattentional and attentional cognitive deficits as targets for treating schizophrenia. Psychopharmacology (Berl) (2004) 1.47
Impairments in generation of early-stage transient visual evoked potentials to magno- and parvocellular-selective stimuli in schizophrenia. Clin Neurophysiol (2005) 1.32
Neurocognitive impairment and HIV risk factors: a reciprocal relationship. AIDS Behav (2010) 1.29
Prepulse inhibition and genetic mouse models of schizophrenia. Behav Brain Res (2009) 1.20
Advances in endophenotyping schizophrenia. World Psychiatry (2008) 1.18
Cognitive dysfunction in chronic hepatitis C: a review. Dig Dis Sci (2007) 1.10
Somatosensory and sensorimotor consequences associated with the heterozygous disruption of the autism candidate gene, Gabrb3. Behav Brain Res (2010) 1.09
Prepulse inhibition of the acoustically evoked startle reflex in patients with an acute schizophrenic psychosis--a longitudinal study. Eur Arch Psychiatry Clin Neurosci (2004) 1.05
Prenatal and postnatal maternal contributions in the infection model of schizophrenia. Exp Brain Res (2006) 1.03
Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats. Psychopharmacology (Berl) (2008) 1.01
Two quantitative trait loci for prepulse inhibition of startle identified on mouse chromosome 16 using chromosome substitution strains. Genetics (2005) 1.00
Genetic and pharmacological evidence for schizophrenia-related Disc1 interaction with GSK-3. Synapse (2011) 0.99
The relationship between sensorimotor gating and clinical improvement in acutely ill schizophrenia patients. Schizophr Res (2006) 0.99
Genetic models of sensorimotor gating: relevance to neuropsychiatric disorders. Curr Top Behav Neurosci (2012) 0.97
Cortical grey matter volume and sensorimotor gating in schizophrenia. Cortex (2008) 0.95
The evolutionarily conserved G protein-coupled receptor SREB2/GPR85 influences brain size, behavior, and vulnerability to schizophrenia. Proc Natl Acad Sci U S A (2008) 0.95
Cognitive deficits in psychiatric disorders: Current status. Indian J Psychiatry (2006) 0.92
A new dimension of sensory dysfunction: stereopsis deficits in schizophrenia. Biol Psychiatry (2006) 0.92
Visual form perception: a comparison of individuals at high risk for psychosis, recent onset schizophrenia and chronic schizophrenia. Schizophr Res (2007) 0.91
Protein Phosphatase 2a and glycogen synthase kinase 3 signaling modulate prepulse inhibition of the acoustic startle response by altering cortical M-Type potassium channel activity. J Neurosci (2010) 0.91
Effect of treatment status on prepulse inhibition of acoustic startle in schizophrenia. Psychopharmacology (Berl) (2003) 0.91
Uncontrollable voices and their relationship to gating deficits in schizophrenia. Schizophr Res (2008) 0.88
The potential role of lamotrigine in schizophrenia. Psychopharmacology (Berl) (2005) 0.87
BDNF deficiency and young-adult methamphetamine induce sex-specific effects on prepulse inhibition regulation. Front Cell Neurosci (2013) 0.86
The GluK4 kainate receptor subunit regulates memory, mood, and excitotoxic neurodegeneration. Neuroscience (2013) 0.85
Prepulse inhibition of startle in adults with ADHD. J Psychiatr Res (2008) 0.83
Sensorimotor gating and clinical outcome following cognitive behaviour therapy for psychosis. Schizophr Res (2011) 0.82
Gsx1 expression defines neurons required for prepulse inhibition. Mol Psychiatry (2014) 0.81
Genetics of schizophrenia: from animal models to clinical studies. J Psychiatry Neurosci (2002) 0.81
Aberrant neural synchrony in the maternal immune activation model: using translatable measures to explore targeted interventions. Front Behav Neurosci (2013) 0.81
Altered prepulse inhibition in rats treated prenatally with the antimitotic Ara-C: an animal model for sensorimotor gating deficits in schizophrenia. Psychopharmacology (Berl) (2004) 0.80
A method to fuse fMRI tasks through spatial correlations: applied to schizophrenia. Hum Brain Mapp (2009) 0.80
Insights and treatment options for psychiatric disorders guided by functional MRI. J Clin Invest (2003) 0.79
Phenomenological dimensions of sensory gating. Schizophr Bull (2010) 0.79
Psychophysiological markers of vulnerability to psychopathology in men with an extra X chromosome (XXY). PLoS One (2011) 0.78
Prepulse inhibition of startle response: recent advances in human studies of psychiatric disease. Clin Psychopharmacol Neurosci (2011) 0.77
The amino acid L-lysine blocks the disruptive effect of phencyclidine on prepulse inhibition in mice. Psychopharmacology (Berl) (2007) 0.77
Missense mutation in DISC1 C-terminal coiled-coil has GSK3β signaling and sex-dependent behavioral effects in mice. Sci Rep (2016) 0.77
Rorschach measures of cognition relate to everyday and social functioning in schizophrenia. Psychol Assess (2012) 0.76
Antioxidant Treatment with N-acetyl Cysteine Prevents the Development of Cognitive and Social Behavioral Deficits that Result from Perinatal Ketamine Treatment. Front Behav Neurosci (2017) 0.76
Global quantitative analysis of phosphorylation underlying phencyclidine signaling and sensorimotor gating in the prefrontal cortex. Mol Psychiatry (2015) 0.75
Reduced Prepulse Inhibition as a Biomarker of Schizophrenia. Front Behav Neurosci (2016) 0.75
Cannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia Pharmacotherapy. Front Pharmacol (2016) 0.75
Axonal conduction block as a novel mechanism of prepulse inhibition. J Neurosci (2012) 0.75
Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? Schizophr Bull (2000) 9.62
Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl) (2001) 4.52
Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology (Berl) (2001) 4.03
Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon. Behav Pharmacol (2000) 3.03
Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch Gen Psychiatry (1994) 1.90
Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology (Berl) (1988) 1.80
Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease. J Neurol Neurosurg Psychiatry (1995) 1.64
Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypal personality disorder: evidence of inhibitory deficits. Am J Psychiatry (2000) 1.60
Sensorimotor gating deficits in bipolar disorder patients with acute psychotic mania. Biol Psychiatry (2001) 1.55
Prefrontal, parietal, and temporal cortex networks underlie decision-making in the presence of uncertainty. Neuroimage (2001) 1.53
A preliminary assessment of sensorimotor gating in patients with obsessive compulsive disorder. Biol Psychiatry (1993) 1.52
Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology (Berl) (1995) 1.48
Startle response models of sensorimotor gating and habituation deficits in schizophrenia. Brain Res Bull (1990) 1.44
Startle habituation and sensorimotor gating in schizophrenia and related animal models. Schizophr Bull (1987) 1.41
Poor P50 suppression among schizophrenia patients and their first-degree biological relatives. Am J Psychiatry (1998) 1.38
Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications. Am J Psychiatry (2000) 1.35
Sensory gating deficits assessed by the P50 event-related potential in subjects with schizotypal personality disorder. Am J Psychiatry (2000) 1.29
Transient versus sustained visual channels in the visual backward masking deficits of schizophrenia patients. Biol Psychiatry (1998) 1.24
Toward understanding the biology of a complex phenotype: rat strain and substrain differences in the sensorimotor gating-disruptive effects of dopamine agonists. J Neurosci (2000) 1.24
Physiological evidence of exaggerated startle response in a subgroup of Vietnam veterans with combat-related PTSD. Am J Psychiatry (1990) 1.21
Magnetic resonance imaging abnormalities in lenticular nuclei and cerebral cortex in schizophrenia. Arch Gen Psychiatry (1991) 1.20
Working memory in schizophrenia: transient "online" storage versus executive functioning. Schizophr Bull (2001) 1.19
Habituation of the Blink reflex in normals and schizophrenic patients. Psychophysiology (1982) 1.19
Automatic sensory information processing abnormalities across the illness course of schizophrenia. Psychol Med (2011) 1.18
Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics. Biol Psychiatry (1986) 1.17
Men are more inhibited than women by weak prepulses. Biol Psychiatry (1993) 1.15
Early information processing deficit in schizophrenia. New findings using schizophrenic subgroups and manic control subjects. Arch Gen Psychiatry (1981) 1.14
The neural substrates of sensorimotor gating of the startle reflex: a review of recent findings and their implications. J Psychopharmacol (1992) 1.13
Cross-species studies of sensorimotor gating of the startle reflex. Ann N Y Acad Sci (1999) 1.10
Environmental enrichment and isolation rearing in the rat: effects on locomotor behavior and startle response plasticity. Biol Psychiatry (2000) 1.10
Sensorimotor gating and thought disturbance measured in close temporal proximity in schizophrenic patients. Arch Gen Psychiatry (1999) 1.09
Positive symptoms of psychosis in posttraumatic stress disorder. Biol Psychiatry (1996) 1.09
Impaired startle prepulse inhibition and habituation in patients with schizotypal personality disorder. Am J Psychiatry (1993) 1.07
Sensory gating deficits in schizophrenia: new results. Am J Psychiatry (1992) 1.06
Increased distractibility in schizophrenic patients. Electrophysiologic and behavioral evidence. Arch Gen Psychiatry (1990) 1.06
P50 suppression among schizophrenia and normal comparison subjects: a methodological analysis. Biol Psychiatry (1997) 1.05
Self-monitoring enhances Wisconsin Card Sorting Test performance in patients with schizophrenia: performance is improved by simply asking patients to verbalize their sorting strategy. J Int Neuropsychol Soc (2001) 1.05
Information processing deficits of schizophrenia patients: relationship to clinical ratings, gender and medication status. Schizophr Res (1997) 1.04
Cognitive functions in schizotypal personality disorder. Schizophr Res (1999) 1.03
Information-processing abnormalities: trait- and state-dependent components. Schizophr Bull (1986) 1.03
Prepulse inhibition and habituation of the startle response are stable neurobiological measures in a normal male population. Biol Psychiatry (1999) 1.02
Human and animal studies of schizophrenia-related gating deficits. Curr Psychiatry Rep (1999) 1.00
Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat. J Pharmacol Exp Ther (1991) 0.99
Effect of antipsychotic medication on speed of information processing in schizophrenic patients. Am J Psychiatry (1982) 0.99
"Normal" personality correlates of sensorimotor, cognitive, and visuospatial gating. Biol Psychiatry (1995) 0.98
Multiple site evaluation of P50 suppression among schizophrenia and normal comparison subjects. Schizophr Res (1998) 0.98
Gender differences in schizophrenia. J Nerv Ment Dis (1995) 0.97
Apomorphine disrupts the inhibition of acoustic startle induced by weak prepulses in rats. Psychopharmacology (Berl) (1990) 0.97
Use of methods from chaos theory to quantify a fundamental dysfunction in the behavioral organization of schizophrenic patients. Am J Psychiatry (1996) 0.97
A D2 dopamine receptor agonist disrupts sensorimotor gating in rats. Implications for dopaminergic abnormalities in schizophrenia. Neuropsychopharmacology (1990) 0.96
Increased sensitivity to the sensorimotor gating-disruptive effects of apomorphine after lesions of medial prefrontal cortex or ventral hippocampus in adult rats. Psychopharmacology (Berl) (1995) 0.95
Amphetamine disruption of prepulse inhibition of acoustic startle is reversed by depletion of mesolimbic dopamine. Psychopharmacology (Berl) (1990) 0.94
Very short-term memory dysfunction in schizophrenia. Defective short time constant information processing in schizophrenia. Arch Gen Psychiatry (1977) 0.93
The relationship of information-processing deficits and clinical symptoms in schizotypal personality disorder. Biol Psychiatry (1996) 0.92
Schizophrenic-like sensorimotor gating abnormalities in rats following dopamine infusion into the nucleus accumbens. Psychopharmacology (Berl) (1990) 0.91
GABAergic projection from nucleus accumbens to ventral pallidum mediates dopamine-induced sensorimotor gating deficits of acoustic startle in rats. Brain Res (1990) 0.91
Information processing dysfunction in paranoid schizophrenia: a two-factor deficit. Am J Psychiatry (1981) 0.89
Measuring P50 suppression and prepulse inhibition in a single recording session. Am J Psychiatry (2001) 0.89
Impaired speed of information processing in nonmedicated schizotypal patients. Schizophr Bull (1981) 0.89
Sex differences in sensorimotor gating of the human startle reflex: all smoke? Psychopharmacology (Berl) (1999) 0.87
Delusions: a review and integration. Schizophr Bull (1991) 0.87
Latent inhibition in schizophrenia. Schizophr Res (1996) 0.86
A multimethod approach to assessing perseverations in schizophrenia patients. Schizophr Res (1998) 0.86
Translating the basic and clinical cognitive neuroscience of schizophrenia to drug development and clinical trials of antipsychotic medications. Biol Psychiatry (2001) 0.85
The abnormality of normal comparison groups: the identification of psychosis proneness and substance abuse in putatively normal research subjects. Am J Psychiatry (1993) 0.85
Long-range correlations in choice sequences of schizophrenic patients. Schizophr Res (1999) 0.84
Amphetamine disrupts P50 suppression in normal subjects. Biol Psychiatry (1999) 0.84
Backward versus forward visual masking deficits in schizophrenic patients: centrally, not peripherally, mediated? Am J Psychiatry (1996) 0.84
Schizophrenia patients demonstrate a dissociation on declarative and non-declarative memory tests. Schizophr Res (2000) 0.84
Impaired speed of visual information processing in marijuana intoxication. Am J Psychiatry (1981) 0.83
Outcome of irregularly discharged psychiatric patients. Am J Psychiatry (1981) 0.83
The time course of information-processing deficits in schizophrenia. Am J Psychiatry (1985) 0.82
Reversal of isolation rearing-induced deficits in prepulse inhibition by Seroquel and olanzapine. Biol Psychiatry (1998) 0.82
Do self-reports of perceptual anomalies reflect gating deficits in schizophrenia patients? Biol Psychiatry (2000) 0.82
Acute and chronic LSD effects on rat startle: data supporting an LSD--rat model of schizophrenia. Biol Psychiatry (1980) 0.82
Sensory gating and inhibitory function in late-life schizophrenia. Schizophr Bull (1993) 0.81
The nonlinear, complex sequential organization of behavior in schizophrenic patients: neurocognitive strategies and clinical correlations. Biol Psychiatry (1999) 0.81
Information processing for masked and unmasked stimuli in schizophrenia and old age. J Abnorm Psychol (1980) 0.80
Prepulse inhibition of the acoustic startle response is disrupted by N-ethyl-3,4-methylenedioxyamphetamine (MDEA) in the rat. Eur J Pharmacol (1989) 0.80
Is there a critical developmental 'window' for isolation rearing-induced changes in prepulse inhibition of the acoustic startle response? Behav Brain Res (1999) 0.79
Trait contributions of complex dysregulated behavioral organization in schizophrenic patients. Biol Psychiatry (2001) 0.79
Effects of task relevance and attention on P3 in schizophrenic patients. Schizophr Res (1991) 0.79
The "incredible shrinking" P50 event-related potential. Biol Psychiatry (1998) 0.79
Middle latency auditory evoked potentials (MAEPs) in chronic schizophrenics. Schizophr Res (1991) 0.78
Information processing in borderline patients. J Nerv Ment Dis (1985) 0.77
Delirium: recognition and management in the older patient. Geriatrics (1986) 0.77
Alprazolam and hostility. Am J Psychiatry (1985) 0.77
The assessment of sequential response organization in schizophrenic and control subjects. Prog Neuropsychopharmacol Biol Psychiatry (1994) 0.76
Wisconsin Card Sorting Test deficits in chronic paranoid schizophrenia. Evidence for a relatively discrete subgroup? Schizophr Res (1992) 0.76
The effect of mental retardation and schizophrenia on information processing. J Nerv Ment Dis (1982) 0.76
Drug screening in "normal" controls. Biol Psychiatry (1995) 0.76
Habituation deficits, serotonergic function, and schizophrenia: new animal model data. Psychopharmacol Bull (1988) 0.76
Atypical postpartum psychosis possibly associated with metronidazole therapy. J Fam Pract (1988) 0.75
Clinical and theoretical consequences of the misuse of basic behavior therapy concepts. Am J Psychiatry (1973) 0.75
Lithium induced cogwheel rigidity: treatment with amantadine. Pharmakopsychiatr Neuropsychopharmakol (1980) 0.75
On the consistency of the MMPI in borderline personality disorder. Percept Mot Skills (1986) 0.75
Intrapsychic structural effects of psychiatric research. Am J Psychiatry (1980) 0.75
AIDS and homosexual panic. Am J Psychiatry (1985) 0.75
Associative cognitive dysfunction in schizophrenia and old age. J Nerv Ment Dis (1980) 0.75
The therapeutic community as a research ward: myths and facts. Arch Gen Psychiatry (1979) 0.75